ImmunityBio (IBRX) Operating Leases (2019 - 2026)
ImmunityBio (IBRX) recorded Operating Leases of $31.2 million in Q2 2026, down 12.9% from $35.84 million a year earlier and down 5.9% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio reported Operating Leases of $33.45 million, down 4.0% from FY2024.
- Annual Operating Leases has declined for three straight years, though with a five-year compound annual growth rate of 15.6% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $34.82 million in FY2024 (-12.8%), $39.94 million in FY2023 (-16.7%), $47.95 million in FY2022 (+29.4%) and $37.07 million in FY2021 (+129.1%).
- The Q2 2026 figure is the lowest quarterly Operating Leases since Q2 2021.
- On a year-over-year basis, Operating Leases rose in 1 of the last eight quarters, with an average decline of 7.3%.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 207.9% in Q3 2021, against a decline of 20.7% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $33.15 million (Q1 2026), $33.45 million (Q4 2025) and $34.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.20 Mn |
| Mar 31, 2026 | 33.15 Mn |
| Dec 31, 2025 | 33.45 Mn |
| Sep 30, 2025 | 34.13 Mn |
| Jun 30, 2025 | 35.84 Mn |
| Mar 31, 2025 | 33.10 Mn |
| Dec 31, 2024 | 34.82 Mn |
| Sep 30, 2024 | 36.76 Mn |
| Jun 30, 2024 | 36.43 Mn |
| Mar 31, 2024 | 38.20 Mn |
| Dec 31, 2023 | 39.94 Mn |
| Sep 30, 2023 | 39.31 Mn |
| Jun 30, 2023 | 44.56 Mn |
| Mar 31, 2023 | 46.29 Mn |
| Dec 31, 2022 | 47.95 Mn |
| Sep 30, 2022 | 49.56 Mn |
| Jun 30, 2022 | 50.65 Mn |
| Mar 31, 2022 | 36.25 Mn |
| Dec 31, 2021 | 37.07 Mn |
| Sep 30, 2021 | 34.64 Mn |
API Access
ImmunityBio Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();